Drug
Vivitrol
Vivitrol: highest development phase Post-Market, developed by Alkermes. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Alkermes
Trials
| Drug | Phase | Indication |
|---|---|---|
| VIVITROL 380mg NCT01453374 | Post-Market | Opioid Dependence |
| VIVITROL 380 mg NCT00511836 | Post-Market | Alcohol Dependence |
Latest
No recent events.
Follow Vivitrol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.